Praxis Precision hits milestone in fight against rare paediatric seizures
The EMBOLD study evaluated relutrigine for patients with SCN2A and SCN8A developmental and epileptic encephalopathies
The EMBOLD study evaluated relutrigine for patients with SCN2A and SCN8A developmental and epileptic encephalopathies
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
StarGuide GX delivers ultra-high sensitivity and high-resolution imaging, enabling fast, confident diagnostics
Abdomen-pelvis CT is the nation’s highest-volume CT category
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor
The Signia Circular Stapler is the only circular stapler on the market with integrated leak testing and features designed to minimize risk
Subscribe To Our Newsletter & Stay Updated